Case Report an Exophytic and Symptomatic Lesion of the Labial Mucosa Diagnosed As Labial Seborrheic Keratosis
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Nutritional Relationships of Zinc David L
The Nutritional Relationships of Zinc David L. Watts, D.C., Ph.D., F.A.C.E.P.i Zinc was discovered to be essential for the also indicate tissue redistribution.12 The normal growth of living organisms in 1869. The range of zinc in the hair has been reported suspicion that zinc deficiency occurs in man is between 15 and 22 milligrams percent,4 the ideal relatively recent. In 1963, studies reported by being 20 milligrams Prasad and co-workers on Iranian men suffering percent. from dwarfism and hypogonadism found that nutritional zinc deficiency was a causative factor Manifestations of Zinc Deficiency Absolute or in these disorders.1 2 3 Since that time zinc has Relative gained a greater recognition for its role in human Manifestations of zinc deficiency will vary health and has stimulated extensive research. It is from one individual to another. This is true of now known that zinc is essential to over 100 almost any nutrient, and can be explained by enzymes in the body. Perhaps one of the most recognizing that two types of a deficiency state important discoveries is zinc's involvement in the can occur, either a relative deficiency, or synthesis of RNA. absolute deficiency. An absolute deficiency develops as a result of inhibited absorption Distribution accompanied by a concurrent increase in zinc The highest concentration of zinc is found in excretion or utilization. TMA patterns usually the choroid of the eye and optic nerve, followed reveal a low tissue zinc (less than 12 mg.%). An by the prostate, bone, liver and kidneys, muscles absolute deficiency of zinc can be contributed to (zinc content varies with colour and function of by hypoadrenocorticism, hyperthyroidism and muscles), heart, spleen, testes, brain, and other endocrine factors. -
The Skin in the Ehlers-Danlos Syndromes
EDS Global Learning Conference July 30-August 1, 2019 (Nashville) The Skin in the Ehlers-Danlos Syndromes Dr Nigel Burrows Consultant Dermatologist MD FRCP Department of Dermatology Addenbrooke’s Hospital Cambridge University NHS Foundation Trust Cambridge, UK No conflict of interests or disclosures Burrows, N: The Skin in EDS 1 EDS Global Learning Conference July 30-August 1, 2019 (Nashville) • Overview of skin and anatomy • Skin features in commoner EDS • Skin features in rarer EDS subtypes • Skin management The skin • Is useful organ to sustain life ØProtection - microorganisms, ultraviolet light, mechanical damage ØSensation ØAllows movement ØEndocrine - vitamin D production ØExcretion - sweat ØTemperature regulation Burrows, N: The Skin in EDS 2 EDS Global Learning Conference July 30-August 1, 2019 (Nashville) The skin • Is useful organ to sustain life • Provides a visual clue to diagnoses • Important for cultures and traditions • Ready material for research Skin Fun Facts • Largest organ in the body • In an average adult the skin weighs approx 5kg (11lbs) and covers 2m2 (21 sq ft) • 11 miles of blood vessels • The average person has about 300 million skin cells • More than half of the dust in your home is actually dead skin • Your skin is home to more than 1,000 species of bacteria Burrows, N: The Skin in EDS 3 EDS Global Learning Conference July 30-August 1, 2019 (Nashville) The skin has 3 main layers Within the Dermis Extracellular Matrix 1. Collagen 2. Elastic fibres 3. Ground Substances i) glycosaminoglycans, ii) proteoglycans, -
Rapid Development of Perifolliculitis Following Mesotherapy
CASE LETTER Rapid Development of Perifolliculitis Following Mesotherapy Weihuang Vivian Ning, MD; Sameer Bashey, MD; Gene H. Kim, MD patient received mesotherapy with an unknown substance PRACTICE POINTS for cosmetic rejuvenation; the rash was localized only to the injection sites.copy She did not note any fever, chills, • Mesotherapy—the delivery of vitamins, chemicals, and plant extracts directly into the dermis via nausea, vomiting, diarrhea, headache, arthralgia, or upper injections—is a common procedure performed respiratory tract symptoms. She further denied starting in both medical and nonmedical settings for any new medications, herbal products, or topical therapies cosmetic rejuvenation. apart from the procedure she had received 2 weeks prior. • Complications can occur from mesotherapy treatment. Thenot patient was found to be in no acute distress and • Patients should be advised to seek medical care with vital signs were stable. Laboratory testing was remarkable US Food and Drug Administration–approved cosmetic for elevations in alanine aminotransferase (62 U/L [refer- techniques and substances only. ence range, 10–40 U/L]) and aspartate aminotransferase (72 U/L [reference range 10–30 U/L]). Moreover, she had Doan absolute neutrophil count of 0.5×103 cells/µL (refer- ence range 1.8–8.0×103 cells/µL). An electrolyte panel, To the Editor: creatinine level, and urinalysis were normal. Physical Mesotherapy, also known as intradermotherapy, is a examination revealed numerous 4- to 5-mm erythematous cosmetic procedure in which multiple -
Immunocompromised Districts of Skin: a Case Series and a Literature Review
ID Design Press, Skopje, Republic of Macedonia Open Access Macedonian Journal of Medical Sciences. 2019 Sep 30; 7(18):2969-2975. https://doi.org/10.3889/oamjms.2019.680 eISSN: 1857-9655 Global Dermatology Immunocompromised Districts of Skin: A Case Series and a Literature Review Aleksandra Vojvodic1, Michael Tirant2,3, Veronica di Nardo2, Torello Lotti2, Uwe Wollina4* 1Department of Dermatology and Venereology, Military Medical Academy of Belgrade, Belgrade, Serbia; 2Department of Dermatology, University of Rome “G. Marconi”, Rome, Italy; 3Hanoi Medical University, Hanoi, Vietnam; 4Department of Dermatology and Allergology, Städtisches Klinikum Dresden, Academic Teaching Hospital, Dresden, Germany Abstract Citation: Vojvodic A, Tirant M, di Nardo V, Lotti T, BACKGROUND: The concept of immunocompromised districts of skin has been developed by Ruocco and helps Wollina U. Immunocompromised Districts of Skin: A Case to explain certain aspects of the macromorphology of skin diseases. This concept unites the isomorphic response Series and a Literature Review. Open Access Maced J Med Sci. 2019 Sep 30; 7(18):2969-2975. of Koebner and the isotopic response of Wolf. https://doi.org/10.3889/oamjms.2019.680 Keywords: Immunocompromised districts of the skin; CASE REPORTS: We present different cutaneous conditions which can lead to immunocompromised districts of Macromorphology of skin diseases; Koebner skin such as scars, radiodermatitis, lymphedema, disturbed innervation or mechanical friction etc. Typical and phenomenon; Wolf’s isotopic response rarer skin disorders associated with them are discussed and illustrated by their observations. *Correspondence: Uwe Wollina. Department of Dermatology and Allergology, Städtisches Klinikum CONCLUSION: At this moment, we wish to inform dermatologists and non-dermatologists about Ruocco’s Dresden, Academic Teaching Hospital, 01067 Dresden, Germany. -
Prior Authorization Topical Retinoids – Tazarotene Products
Cigna National Formulary Coverage Policy Prior Authorization Topical Retinoids – Tazarotene Products Table of Contents Product Identifier(s) National Formulary Medical Necessity ................ 1 01541 Conditions Not Covered....................................... 2 Background .......................................................... 2 References .......................................................... 2 Revision History ................................................... 3 INSTRUCTIONS FOR USE The following Coverage Policy applies to health benefit plans administered by Cigna Companies. Certain Cigna Companies and/or lines of business only provide utilization review services to clients and do not make coverage determinations. References to standard benefit plan language and coverage determinations do not apply to those clients. Coverage Policies are intended to provide guidance in interpreting certain standard benefit plans administered by Cigna Companies. Please note, the terms of a customer’s particular benefit plan document [Group Service Agreement, Evidence of Coverage, Certificate of Coverage, Summary Plan Description (SPD) or similar plan document] may differ significantly from the standard benefit plans upon which these Coverage Policies are based. For example, a customer’s benefit plan document may contain a specific exclusion related to a topic addressed in a Coverage Policy. In the event of a conflict, a customer’s benefit plan document always supersedes the information in the Coverage Policies. In the absence of a controlling federal or state coverage mandate, benefits are ultimately determined by the terms of the applicable benefit plan document. Coverage determinations in each specific instance require consideration of 1) the terms of the applicable benefit plan document in effect on the date of service; 2) any applicable laws/regulations; 3) any relevant collateral source materials including Coverage Policies and; 4) the specific facts of the particular situation. -
A Patient with Plaque Type Morphea Mimicking Systemic Lupus Erythematosus
CASE REPORT A Patient With Plaque Type Morphea Mimicking Systemic Lupus Erythematosus Wardhana1, EA Datau2 1 Department of Internal Medicine, Siloam International Hospitals. Karawaci, Indonesia. 2 Department of Internal Medicine, Prof. Dr. RD Kandou General Hospital & Sitti Maryam Islamic Hospital, Manado, North Sulawesi, Indonesia. Correspondence mail: Siloam Hospitals Group’s CEO Office, Siloam Hospital Lippo Village. 5th floor. Jl. Siloam No.6, Karawaci, Indonesia. email: [email protected] ABSTRAK Morfea merupakan penyakit jaringan penyambung yang jarang dengan gambaran utama berupa penebalan dermis tanpa disertai keterlibatan organ dalam. Penyakit ini juga dikenal sebagai bagian dari skleroderma terlokalisir. Berdasarkan gambaran klinis dan kedalaman jaringan yang terlibat, morfea dikelompokkan ke dalam beberapa bentuk dan sekitar dua pertiga orang dewasa dengan morfea mempunyai tipe plak. Produksi kolagen yang berlebihan oleh fibroblast merupakan penyebab kelainan pada morfea dan mekanisme terjadinya aktivitas fibroblast yang berlebihan ini masih belum diketahui, meskipun beberapa mekanisme pernah diajukan. Morfe tipe plak biasanya bersifat ringan dan dapat sembuh dengan sendirinya. Morfea tipe plak yang penampilan klinisnya menyerupai lupus eritematosus sistemik, misalnya meliputi alopesia dan ulkus mukosa di mulut, jarang dijumpai. Sebuah kasus morfea tipe plak pada wanita berusia 20 tahun dibahas. Pasien ini diobati dengan imunosupresan dan antioksidan local maupun sistemik. Kondisi paisen membaik tanpa disertai efek samping yang berarti. Kata kunci: morfea, tipe plak. ABSTRACT Morphea is an uncommon connective tissue disease with the most prominent feature being thickening or fibrosis of the dermal without internal organ involvement. It is also known as a part of localized scleroderma. Based on clinical presentation and depth of tissue involvement, morphea is classified into several forms, and about two thirds of adults with morphea have plaque type. -
Fundamentals of Dermatology Describing Rashes and Lesions
Dermatology for the Non-Dermatologist May 30 – June 3, 2018 - 1 - Fundamentals of Dermatology Describing Rashes and Lesions History remains ESSENTIAL to establish diagnosis – duration, treatments, prior history of skin conditions, drug use, systemic illness, etc., etc. Historical characteristics of lesions and rashes are also key elements of the description. Painful vs. painless? Pruritic? Burning sensation? Key descriptive elements – 1- definition and morphology of the lesion, 2- location and the extent of the disease. DEFINITIONS: Atrophy: Thinning of the epidermis and/or dermis causing a shiny appearance or fine wrinkling and/or depression of the skin (common causes: steroids, sudden weight gain, “stretch marks”) Bulla: Circumscribed superficial collection of fluid below or within the epidermis > 5mm (if <5mm vesicle), may be formed by the coalescence of vesicles (blister) Burrow: A linear, “threadlike” elevation of the skin, typically a few millimeters long. (scabies) Comedo: A plugged sebaceous follicle, such as closed (whitehead) & open comedones (blackhead) in acne Crust: Dried residue of serum, blood or pus (scab) Cyst: A circumscribed, usually slightly compressible, round, walled lesion, below the epidermis, may be filled with fluid or semi-solid material (sebaceous cyst, cystic acne) Dermatitis: nonspecific term for inflammation of the skin (many possible causes); may be a specific condition, e.g. atopic dermatitis Eczema: a generic term for acute or chronic inflammatory conditions of the skin. Typically appears erythematous, -
Systemic Lupus Erythematosus and Granulomatous Lymphadenopathy
Shrestha et al. BMC Pediatrics 2013, 13:179 http://www.biomedcentral.com/1471-2431/13/179 CASE REPORT Open Access Systemic lupus erythematosus and granulomatous lymphadenopathy Devendra Shrestha1*, Ajaya Kumar Dhakal1, Shiva Raj KC2, Arati Shakya1, Subhash Chandra Shah1 and Henish Shakya1 Abstract Background: Systemic lupus erythematosus (SLE) is known to present with a wide variety of clinical manifestations. Lymphadenopathy is frequently observed in children with SLE and may occasionally be the presenting feature. SLE presenting with granulomatous changes in lymph node biopsy is rare. These features may also cause diagnostic confusion with other causes of granulomatous lymphadenopathy. Case presentation: We report 12 year-old female who presented with generalized lymphadenopathy associated with intermittent fever as well as weight loss for three years. She also had developed anasarca two years prior to presentation. On presentation, she had growth failure and delayed puberty. Lymph node biopsy revealed granulomatous features. She developed a malar rash, arthritis and positive ANA antibodies over the course of next two months and showed WHO class II lupus nephritis on renal biopsy, which confirmed the final diagnosis of SLE. She was started on oral prednisolone and hydroxychloroquine with which her clinical condition improved, and she is currently much better under regular follow up. Conclusion: Generalized lymphadenopathy may be the presenting feature of SLE and it may preceed the other symptoms of SLE by many years as illustrated by this patient. Granulomatous changes may rarely be seen in lupus lymphadenitis. Although uncommon, in children who present with generalized lymphadenopathy along with prolonged fever and constitutional symptoms, non-infectious causes like SLE should also be considered as a diagnostic possibility. -
Acanthosis Nigricans As a Presentation of Severe Insulin
Acanthosis nigricans as a presentation of severe insulin resistance in obese children - a case report - Maria Krajewska, Jędrzej Nowaczyk, Dominika Labochka, Anna Kucharska, Beata Pyrżak Department of Paediatrics and Endocrinology, Medical University of Warsaw, Poland Acanthosis nigricans • Acanthosis nigricans is well known as the skin symptom of insulin resistance, nevertheless children with such skin disorders usually undergo a long way until they are properly diagnosed. • We would like to present the history of two young patients with severe acanthosis nigricans combined with insulin resistance of major grade. Patient 1 Patient 2 A 13-year-old boy referred to the Clinic by dermatologist due to acanthosis nigricans and obesity. A 14-year-old boy referred to the Clinic by general pediatrician due to acanthosis nigricans and obesity. Medical history: Medical history: •born with the forces of nature, from uncomplicated pregnancy, 40 weeks, with body weight 2700g. Delayed • born from uncomplicated pregnancy with the forces of nature, 38 weeks, body psychomotor development since the infancy period. Negative history of chronic diseases and taking weight 3100g, length 51 cm, in infancy fed with modified milk, negative history medications of chronic diseases and taking medications •excessive body weight from the early childhood: • excessive body weight from the age of five: frequent and irregular eating insufficient physical activity frequent and irregular eating, large amounts of sweets and sweet drinks (up to •family history: grandmother suffers from type 2 diabetes, brother is suffering from autism, negative history of 4-5 liters per day), insufficient physical activity; familial acanthosis nigricans and obesity acanthosis nigricans was noticed at the age of 12 years. -
Tumid Lupus Erythematosus
Tumid Lupus Erythematosus Sylvia Hsu, MD; Linda Y. Hwang, MD; Hiram Ruiz, MD Tumid lupus erythematosus (TLE) is a variant of cutaneous lupus erythematosus. Most patients who present with these skin lesions are young women. The condition clinically resembles polymorphous light eruption, systemic lupus ery- thematosus (SLE), reticulated erythematous mucinosis, or gyrate erythema. Histopathologi- cally, the lesions resemble classic lupus erythem- atosus because of their superficial and deep lymphohistiocytic inflammatory infiltrates and dermal mucin. However, unlike classic lupus ery- thematosus, there is little or no epidermal or dermo-epidermal involvement. Antinuclear anti- body test results are usually negative. We describe 4 cases of TLE and discuss the differ- ential diagnosis. here have been few reports of tumid lupus erythematosus (TLE) in the literature.1-4 T Most major textbooks of dermatology or Figure 1. Erythematous papules and plaques on the dermatopathology mention this entity only briefly, chest of patient 1. if at all. Ackerman et al5 consider TLE to be a manifestation of discoid lupus erythematosus (DLE). We describe 4 patients with TLE and review the her chest, upper extremities, and face (Figure 1). list of controversial entities that overlap clinically Test results for antinuclear antibodies (ANA), Ro, and histologically with TLE. La, and dsDNA were all negative. Histopathology results revealed superficial and deep perivascular Case Reports and periadnexal lymphohistiocytic infiltrates with Patient 1—A 34-year-old white woman presented dermal mucin. There was no involvement of the with an 8-year history of asymptomatic lesions on epidermis, the dermo-epidermal junction, or the her face, neck, chest, and upper extremities. -
Clinical Spectrum of Lyme Disease
European Journal of Clinical Microbiology & Infectious Diseases (2019) 38:201–208 https://doi.org/10.1007/s10096-018-3417-1 REVIEW Clinical spectrum of Lyme disease Jesus Alberto Cardenas-de la Garza1 & Estephania De la Cruz-Valadez1 & Jorge Ocampo-Candiani 1 & Oliverio Welsh1 Received: 4 September 2018 /Accepted: 30 October 2018 /Published online: 19 November 2018 # Springer-Verlag GmbH Germany, part of Springer Nature 2018 Abstract Lyme disease (borreliosis) is one of the most common vector-borne diseases worldwide. Its incidence and geographic expansion has been steadily increasing in the last decades. Lyme disease is caused by Borrelia burgdorferi sensu lato, a heterogeneous group of which three genospecies have been systematically associated to Lyme disease: B. burgdorferi sensu stricto Borrelia afzelii and Borrelia garinii. Geographical distribution and clinical manifestations vary according to the species involved. Lyme disease clinical manifestations may be divided into three stages. Early localized stage is characterized by erythema migrans in the tick bite site. Early disseminated stage may present multiple erythema migrans lesions, borrelial lymphocytoma, lyme neuroborreliosis, carditis, or arthritis. The late disseminated stage manifests with acordermatitis chronica atrophicans, lyme arthritis, and neurological symptoms. Diagnosis is challenging due to the varied clinical manifestations it may present and usually involves a two-step serological approach. In the current review, we present a thorough revision of the clinical manifestations Lyme disease may present. Additionally, history, microbiology, diagnosis, post-treatment Lyme disease syndrome, treatment, and prognosis are discussed. Keywords Lyme disease . Borrelia burgdorferi . Tick-borne diseases . Ixodes . Erythema migrans . Lyme neuroborreliosis History posteriorly meningitis, establishing a link between both mani- festations. -
Excimer Laser for Treatment of Psoriasis
Excimer and Pulsed Dye Laser Treatment Last Revision/Review Date: May 19, 2021 P&P # C.6.28 Policy This Medical Policy does not constitute medical advice. When deciding coverage, the enrollee’s specific plan document must be referenced. The terms of an enrollee’s plan document (Certificate of Coverage (COC) or Summary Plan Description (SPD)) may differ from this Medical Policy. In the event of a conflict, the enrollee’s specific benefit plan document supersedes this Medical Policy. All reviewers must first identify enrollee eligibility, any federal or state regulatory requirements, and the plan benefit coverage prior to use of this Medical Policy. Other Policies and Coverage Determination Guidelines may apply. Quartz reserves the right, in its sole discretion, to modify its Policies and Guidelines as necessary. Procedure I. Excimer Laser Treatment of Psoriasis and Vitiligo A. Documentation Required: In order to facilitate the authorization process, referral requests must include the following: 1. Dermatologist documentation of mild to moderate localized psoriasis vulgaris (plaque psoriasis) or vitiligo of the face and neck. 2. Dermatologist documentation of percent body surface area of plaque psoriasis to be treated. 3. Dermatologist documentation of failed response to previous treatment. 4. Order from a dermatologist B. Criteria for Medical Necessity-Psoriasis Initial Course of Treatment Up to 13 excimer laser treatments using an FDA approved device is considered medically necessary for the treatment of mild to moderate localized plaque psoriasis if BOTH of the following are met: 1. Treatment area of localized plaque psoriasis affects 10% or less of body surface area; AND 2. Failed response to 3 or more consecutive months of topical treatments from at least 3 of the following: a.